Cargando…

Evaluating the impact of varying expired carbon monoxide thresholds on smoking relapse identification: insights from the E3 trial on e-cigarette efficacy for smoking cessation

OBJECTIVES: Expired carbon monoxide (ECO) is often used in smoking cessation trials to biochemically validate self-reported smoking status. The optimal ECO threshold to distinguish individuals who smoke from those who do not is debated. DESIGN: The data from the ‘Evaluating the Efficacy of E-Cigaret...

Descripción completa

Detalles Bibliográficos
Autores principales: Prell, Celine, Hébert-Losier, Andréa, Filion, Kristian B., Reynier, Pauline, Eisenberg, Mark J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583027/
https://www.ncbi.nlm.nih.gov/pubmed/37832989
http://dx.doi.org/10.1136/bmjopen-2022-071099
_version_ 1785122469198168064
author Prell, Celine
Hébert-Losier, Andréa
Filion, Kristian B.
Reynier, Pauline
Eisenberg, Mark J.
author_facet Prell, Celine
Hébert-Losier, Andréa
Filion, Kristian B.
Reynier, Pauline
Eisenberg, Mark J.
author_sort Prell, Celine
collection PubMed
description OBJECTIVES: Expired carbon monoxide (ECO) is often used in smoking cessation trials to biochemically validate self-reported smoking status. The optimal ECO threshold to distinguish individuals who smoke from those who do not is debated. DESIGN: The data from the ‘Evaluating the Efficacy of E-Cigarette use for Smoking Cessation (E3) Trial’ were used; the E3 trial was a randomised controlled trial that examined e-cigarettes efficacy for smoking cessation. SETTINGS: Participants were recruited from 17 Canadian sites across 4 provinces. PARTICIPANTS: This substudy included data from participants who returned for at least one of the clinical visits at week 4 (291), 12 (257) or 24 (218) and provided both self-reported smoking status and ECO measures. Analyses were based on 766 paired measures (ie, self-reported smoking status with corresponding ECO). RESULTS: The ability of ECO measurements to discriminate between adults who reported smoking and those who reported abstinence varied with the threshold used. ECO thresholds of 6, 7, 8 and 9 parts per million (ppm) yielded the greatest area under the receiver operating characteristic curve (0.84). These thresholds produced sensitivities of 84%, 82%, 78% and 76% and specificities of 84%, 87%, 90% and 91%, respectively. However, at a threshold of 6 ppm, intersecting sensitivity (84%) and specificity (84%) were maximised with respect to each other. Biochemical validation had the highest agreement with self-report at an ECO threshold of 6 ppm (κ=0.57; 95% CI, 0.51 to 0.64). CONCLUSION: The classification of participants’ smoking status depends on the ECO threshold used for biochemical validation. We recommend that future smoking cessation trial investigators analyse and report the impact that varying ECO thresholds has on trial results. TRIAL REGISTRATION NUMBER: NCT02417467.
format Online
Article
Text
id pubmed-10583027
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-105830272023-10-19 Evaluating the impact of varying expired carbon monoxide thresholds on smoking relapse identification: insights from the E3 trial on e-cigarette efficacy for smoking cessation Prell, Celine Hébert-Losier, Andréa Filion, Kristian B. Reynier, Pauline Eisenberg, Mark J. BMJ Open Smoking and Tobacco OBJECTIVES: Expired carbon monoxide (ECO) is often used in smoking cessation trials to biochemically validate self-reported smoking status. The optimal ECO threshold to distinguish individuals who smoke from those who do not is debated. DESIGN: The data from the ‘Evaluating the Efficacy of E-Cigarette use for Smoking Cessation (E3) Trial’ were used; the E3 trial was a randomised controlled trial that examined e-cigarettes efficacy for smoking cessation. SETTINGS: Participants were recruited from 17 Canadian sites across 4 provinces. PARTICIPANTS: This substudy included data from participants who returned for at least one of the clinical visits at week 4 (291), 12 (257) or 24 (218) and provided both self-reported smoking status and ECO measures. Analyses were based on 766 paired measures (ie, self-reported smoking status with corresponding ECO). RESULTS: The ability of ECO measurements to discriminate between adults who reported smoking and those who reported abstinence varied with the threshold used. ECO thresholds of 6, 7, 8 and 9 parts per million (ppm) yielded the greatest area under the receiver operating characteristic curve (0.84). These thresholds produced sensitivities of 84%, 82%, 78% and 76% and specificities of 84%, 87%, 90% and 91%, respectively. However, at a threshold of 6 ppm, intersecting sensitivity (84%) and specificity (84%) were maximised with respect to each other. Biochemical validation had the highest agreement with self-report at an ECO threshold of 6 ppm (κ=0.57; 95% CI, 0.51 to 0.64). CONCLUSION: The classification of participants’ smoking status depends on the ECO threshold used for biochemical validation. We recommend that future smoking cessation trial investigators analyse and report the impact that varying ECO thresholds has on trial results. TRIAL REGISTRATION NUMBER: NCT02417467. BMJ Publishing Group 2023-10-13 /pmc/articles/PMC10583027/ /pubmed/37832989 http://dx.doi.org/10.1136/bmjopen-2022-071099 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Smoking and Tobacco
Prell, Celine
Hébert-Losier, Andréa
Filion, Kristian B.
Reynier, Pauline
Eisenberg, Mark J.
Evaluating the impact of varying expired carbon monoxide thresholds on smoking relapse identification: insights from the E3 trial on e-cigarette efficacy for smoking cessation
title Evaluating the impact of varying expired carbon monoxide thresholds on smoking relapse identification: insights from the E3 trial on e-cigarette efficacy for smoking cessation
title_full Evaluating the impact of varying expired carbon monoxide thresholds on smoking relapse identification: insights from the E3 trial on e-cigarette efficacy for smoking cessation
title_fullStr Evaluating the impact of varying expired carbon monoxide thresholds on smoking relapse identification: insights from the E3 trial on e-cigarette efficacy for smoking cessation
title_full_unstemmed Evaluating the impact of varying expired carbon monoxide thresholds on smoking relapse identification: insights from the E3 trial on e-cigarette efficacy for smoking cessation
title_short Evaluating the impact of varying expired carbon monoxide thresholds on smoking relapse identification: insights from the E3 trial on e-cigarette efficacy for smoking cessation
title_sort evaluating the impact of varying expired carbon monoxide thresholds on smoking relapse identification: insights from the e3 trial on e-cigarette efficacy for smoking cessation
topic Smoking and Tobacco
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583027/
https://www.ncbi.nlm.nih.gov/pubmed/37832989
http://dx.doi.org/10.1136/bmjopen-2022-071099
work_keys_str_mv AT prellceline evaluatingtheimpactofvaryingexpiredcarbonmonoxidethresholdsonsmokingrelapseidentificationinsightsfromthee3trialonecigaretteefficacyforsmokingcessation
AT hebertlosierandrea evaluatingtheimpactofvaryingexpiredcarbonmonoxidethresholdsonsmokingrelapseidentificationinsightsfromthee3trialonecigaretteefficacyforsmokingcessation
AT filionkristianb evaluatingtheimpactofvaryingexpiredcarbonmonoxidethresholdsonsmokingrelapseidentificationinsightsfromthee3trialonecigaretteefficacyforsmokingcessation
AT reynierpauline evaluatingtheimpactofvaryingexpiredcarbonmonoxidethresholdsonsmokingrelapseidentificationinsightsfromthee3trialonecigaretteefficacyforsmokingcessation
AT eisenbergmarkj evaluatingtheimpactofvaryingexpiredcarbonmonoxidethresholdsonsmokingrelapseidentificationinsightsfromthee3trialonecigaretteefficacyforsmokingcessation